Normal development and function of dendritic cells in mice lacking IDO-1 expression

Immunology Letters

Volumn 118, Issue 1, 2008, Pages 21-29

  de Faudeur, Geoffroy ^a   de Trez, Carl ^a   Muraille, Eric ^a   Leo, Oberdan ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Bone marrow derived dendritic cells; Indoleamine 2,3 dioxygenase; Splenic dendritic cells

Indexed keywords

FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3 DIOXYGENASE 1;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WILD TYPE;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; ISOENZYMES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PHENOTYPE;

EID: 43849102537     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.02.006     Document Type: Article

References (45)

1. Villadangos J.A., and Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol 7 (2007) 543-555
2. Wu L., and Liu Y.J. Development of dendritic-cell lineages. Immunity 26 (2007) 741-750
3. Reis e Sousa C. Dendritic cells in a mature age. Nat Rev Immunol 6 (2006) 476-483
4. Morelli A.E., and Thomson A.W. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 7 (2007) 610-621
5. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 194 (2001) 769-779
6. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu Rev Immunol 21 (2003) 685-711
7. Dhodapkar M.V., Steinman R.M., Krasovsky J., Munz C., and Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 193 (2001) 233-238
8. Fujita S., Seino K., Sato K., Sato Y., Eizumi K., Yamashita N., et al. Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response. Blood 107 (2006) 3656-3664
9. Probst H.C., McCoy K., Okazaki T., Honjo T., and van den Broek M. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat Immunol 6 (2005) 280-286
10. Wakkach A., Fournier N., Brun V., Breittmayer J.P., Cottrez F., and Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18 (2003) 605-617
11. Mellor A.L., and Munn D.H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4 (2004) 762-774
12. Munn D.H., Sharma M.D., Lee J.R., Jhaver K.G., Johnson T.S., Keskin D.B., et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297 (2002) 1867-1870
13. Swanson K.A., Zheng Y., Heidler K.M., Mizobuchi T., and Wilkes D.S. CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase. Am J Respir Cell Mol Biol 30 (2004) 311-318
14. Fallarino F., Grohmann U., Hwang K.W., Orabona C., Vacca C., Bianchi R., et al. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 4 (2003) 1206-1212
15. Grohmann U., Orabona C., Fallarino F., Vacca C., Calcinaro F., Falorni A., et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 3 (2002) 1097-1101
16. MacKenzie C.R., Hadding U., and Daubener W. Interferon-gamma-induced activation of indoleamine 2,3-dioxygenase in cord blood monocyte-derived macrophages inhibits the growth of group B streptococci. J Infect Dis 178 (1998) 875-878
17. Pfefferkorn E.R. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci USA 81 (1984) 908-912
18. Taylor M.W., and Feng G.S. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 5 (1991) 2516-2522
19. Munn D.H., Zhou M., Attwood J.T., Bondarev I., Conway S.J., Marshall B., et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281 (1998) 1191-1193
20. Mellor A.L., Sivakumar J., Chandler P., Smith K., Molina H., Mao D., et al. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2 (2001) 64-68
21. Munn D.H., Shafizadeh E., Attwood J.T., Bondarev I., Pashine A., and Mellor A.L. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 189 (1999) 1363-1372
22. Munn D.H., Sharma M.D., Baban B., Harding H.P., Zhang Y., Ron D., et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 22 (2005) 633-642
23. Terness P., Bauer T.M., Rose L., Dufter C., Watzlik A., Simon H., et al. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 196 (2002) 447-457
24. Frumento G., Rotondo R., Tonetti M., Damonte G., Benatti U., and Ferrara G.B. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 196 (2002) 459-468
25. Bauer T.M., Jiga L.P., Chuang J.J., Randazzo M., Opelz G., and Terness P. Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo. Transpl Int 18 (2005) 95-100
26. Fallarino F., Grohmann U., Vacca C., Bianchi R., Orabona C., Spreca A., et al. T cell apoptosis by tryptophan catabolism. Cell Death Differ 9 (2002) 1069-1077
27. Hwang S.L., Chung N.P., Chan J.K., and Lin C.L. Indoleamine 2,3-dioxygenase (IDO) is essential for dendritic cell activation and chemotactic responsiveness to chemokines. Cell Res 15 (2005) 167-175
28. Hill M., Tanguy-Royer S., Royer P., Chauveau C., Asghar K., Tesson L., et al. IDO expands human CD4(+)CD25(high) regulatory T cells by promoting maturation of LPS-treated dendritic cells. Eur J Immunol 37 (2007) 3054-3062
29. Puccetti P., and Fallarino F. Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism. Blood Cells Mol Dis 40 (2008) 101-105
30. Sharma M.D., Baban B., Chandler P., Hou D.Y., Singh N., Yagita H., et al. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest 117 (2007) 2570-2582
31. Shortman K., and Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 7 (2007) 19-30
32. Marshall B., Keskin D.B., and Mellor A.L. Regulation of prostaglandin synthesis and cell adhesion by a tryptophan catabolizing enzyme. BMC Biochem 2 (2001) 5
33. Ball H.J., Sanchez-Perez A., Weiser S., Austin C.J., Astelbauer F., Miu J., et al. Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene 396 (2007) 203-213
34. Leon B., Lopez-Bravo M., and Ardavin C. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 26 (2007) 519-531
35. Banchereau J., and Palucka A.K. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 5 (2005) 296-306
36. Mellor A.L., and Munn D.H. Creating immune privilege: active local suppression that benefits friends, but protects foes. Nat Rev Immunol 8 (2008) 74-80
37. Mellor A.L., Baban B., Chandler P.R., Manlapat A., Kahler D.J., and Munn D.H. Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling. J Immunol 175 (2005) 5601-5605
38. Agaugue S., Perrin-Cocon L., Coutant F., Andre P., and Lotteau V. 1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity. J Immunol 177 (2006) 2061-2071
39. Uyttenhove C., Pilotte L., Theate I., Stroobant V., Colau D., Parmentier N., et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 9 (2003) 1269-1274
40. Munn D.H., and Mellor A.L. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 117 (2007) 1147-1154
41. Munn D.H., Sharma M.D., Hou D., Baban B., Lee J.R., Antonia S.J., et al. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest 114 (2004) 280-290
42. Baban B., Chandler P., McCool D., Marshall B., Munn D.H., and Mellor A.L. Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific. J Reprod Immunol 61 (2004) 67-77
43. Muraille E., De Trez C., Brait M., De Baetselier P., Leo O., and Carlier Y. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response. J Immunol 170 (2003) 4237-4241
44. Brawand P., Fitzpatrick D.R., Greenfield B.W., Brasel K., Maliszewski C.R., and De Smedt T. Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs. J Immunol 169 (2002) 6711-6719
45. + regulatory T cells control the magnitude of T-dependent humoral immune responses to exogenous antigens. Eur J Immunol 36 (2006) 855-863